select a format

Single User License
USD 2500 INR 161075
Site License
USD 5000 INR 322150
Corporate User License
USD 7500 INR 483225

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Thromboembolism Global Clinical Trials Review, H1, 2015

Thromboembolism Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2631CTIDB
  • |
  • Pages: 96
  • |
  • April 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Thromboembolism Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Thromboembolism Global Clinical Trials Review, H1, 2015" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Thromboembolism 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Thromboembolism to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Thromboembolism to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Thromboembolism 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Thromboembolism Therapeutics Clinical Trials 33

Prominent Drugs 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

C. H. Boehringer Sohn AG & Co. KG 35

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35

Bayer AG 40

Clinical Trial Overview of Bayer AG 40

Sanofi 43

Clinical Trial Overview of Sanofi 43

GlaxoSmithKline plc 45

Clinical Trial Overview of GlaxoSmithKline plc 45

Pfizer Inc. 47

Clinical Trial Overview of Pfizer Inc. 47

Bristol-Myers Squibb Company 49

Clinical Trial Overview of Bristol-Myers Squibb Company 49

Astellas Pharma Inc. 51

Clinical Trial Overview of Astellas Pharma Inc. 51

Daiichi Sankyo Company, Limited 53

Clinical Trial Overview of Daiichi Sankyo Company, Limited 53

AstraZeneca PLC 55

Clinical Trial Overview of AstraZeneca PLC 55

Johnson & Johnson 57

Clinical Trial Overview of Johnson & Johnson 57

Clinical Trial Overview of Top Institutes / Government 58

Beijing Chao-Yang Hospital 58

Clinical Trial Overview of Beijing Chao-Yang Hospital 58

McMaster University 59

Clinical Trial Overview of McMaster University 59

Ottawa Hospital Research Institute 60

Clinical Trial Overview of Ottawa Hospital Research Institute 60

Capital District Health Authority, Canada 61

Clinical Trial Overview of Capital District Health Authority, Canada 61

Hamilton Health Sciences 62

Clinical Trial Overview of Hamilton Health Sciences 62

National Institutes of Health Clinical Center 63

Clinical Trial Overview of National Institutes of Health Clinical Center 63

Seoul National University Hospital 64

Clinical Trial Overview of Seoul National University Hospital 64

The Utrecht Institute for Pharmaceutical Sciences 65

Clinical Trial Overview of The Utrecht Institute for Pharmaceutical Sciences 65

Universita degli Studi dell'Insubria 66

Clinical Trial Overview of Universita degli Studi dell'Insubria 66

Five Key Clinical Profiles 67

Appendix 94

Abbreviations 94

Definitions 94

Research Methodology 95

Secondary Research 95

About GlobalData 96

Contact Us 96

Disclaimer 96

Source 96

List of Figures

Thromboembolism Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Thromboembolism Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 95

List of Tables

Thromboembolism Therapeutics, Global, Clinical Trials by Region, 2015* 7

Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Thromboembolism Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Thromboembolism Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Thromboembolism Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Thromboembolism Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 35

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 40

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 43

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 45

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 47

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 49

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 51

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 53

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 55

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 57

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao-Yang Hospital, 2015* 58

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 59

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015* 60

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 61

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2015* 62

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2015* 63

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 64

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The Utrecht Institute for Pharmaceutical Sciences, 2015* 65

Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi dell'Insubria, 2015* 66

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Thromboembolism Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Thromboembolism, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com